Ceribell (CBLL) Gains from Investment Securities (2023 - 2024)
Ceribell's (CBLL) quarterly Gains from Investment Securities came in at $1.1 million in Q4 2024, up 523.7% quarter-over-quarter from $173000.0 in Q3 2024.
Powered by 
Analysis
Ceribell (CBLL) Gains from Investment Securities (2023 - 2024) Analysis & Trends
Ceribell (CBLL) has reported Gains from Investment Securities for 2 consecutive years, with $1.1 million the latest figure, recorded in Q4 2024.
- For the quarter ending Q4 2024, Gains from Investment Securities changed N/A year-over-year to $1.1 million; the trailing twelve-month figure through Dec 2025 stood at $1.3 million (down 16.31% YoY), and the FY2024 full-year result was $1.5 million, up 3216.67% from the prior year.
- Gains from Investment Securities climbed to $1.1 million in Q4 2024 per CBLL's latest filing, from $173000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $1.1 million in Q4 2024 and bottomed at $2000.0 in Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - |
| 10 | Prenetics Global | 339.92 Mn | 280.78 Mn | 30.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 1.08 Mn |
| Sep 30, 2024 | 173,000.00 |
| Jun 30, 2024 | 242,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Sep 30, 2023 | 3,000.00 |